ECM
ETON icon

ExodusPoint Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

ExodusPoint Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,102
Closed -$222K – 1600
2025
Q1 		$222K Buy
+17,102
New +$258K ﹤0.01% 1283
2022
Q1 		– Sell
-13,212
Closed -$57K – 2317
2021
Q4 		$57K Buy
+13,212
New +$63.2K ﹤0.01% 2017
2021
Q2 		– Sell
-11,100
Closed -$81K – 2479
2021
Q1 		$81K Buy
+11,100
New +$94.7K ﹤0.01% 2000

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

ExodusPoint Capital Management's ETON Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 17,102 shares — an estimated $222K sold.

ExodusPoint Capital Management first reported a position in ETON in Q1 2021 and held it in 3 quarters. The position peaked at $222K in Q1 2025. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 17,102 Eton Pharmaceutcials shares in Q2 2025, an estimated $222K.
  • ExodusPoint Capital Management first reported a position in Eton Pharmaceutcials in Q1 2021 and held it in 3 quarters.
  • ExodusPoint Capital Management's Eton Pharmaceutcials position peaked at $222K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.